Exhibit 32.1


              CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with  the  IGENE Biotechnology,  Inc.  (the
"Company")  Quarterly Report on Form 10-Q for  the  period  ended
September  30,  2010, as filed with the Securities  and  Exchange
Commission  (the "Report"), I, Stephen F. Hiu, President  of  the
Company,  certify pursuant to 18 U.S.C. Section 1350, as  adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,  that,
to the best of my knowledge:

          (1). The Report fully complies with the requirements of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934, as amended; and

          (2).  The  information contained in the  Report  fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Company.


Date: November 15, 2010            By:  /S/ STEPHEN F. HIU
      _________________                 _________________________
                                            STEPHEN F. HIU
                                            President


A  signed original of this written statement required by  Section
906  has been provided to the Company and will be retained by the
Company  and furnished to the Securities and Exchange  Commission
or its staff upon request.